Welcome back to the REFLECTIONS Hypertension Global Newsletter series, which draws on the expertise of international physicians to summarize the latest clinical and real-world evidence in the field of hypertension and reflect on the clinical impact of these new data on the management of patients with hypertension.

Since our last newsletter, there have been very many new and interesting publications in the active field of clinical research in hypertension, therefore the Scientific Planning Committee was tasked with choosing from an extensive list of articles from high-quality scientific journals. To make this last selection, we privileged novel findings rather than confirmation papers, and articles directly applying to anti-hypertensive treatment in routine clinical practice.

This newsletter will focus on

1. Recent clinical guidelines from the ESC and the AHA,
2. Targets and treatments, and
3. Special populations – obesity.

As with previous newsletters, we invite you to interact with this through links to commentary videos from authors of the publications, short video clinical perspectives from our SPC, and delve into the articles through hyperlinks for in-depth study. We are also pleased to share our Conference Corner, where this time we highlight some abstracts of interest from the recent 2024 ESC Congress which took place in London, England.

Prof. Laurent (Chair)